DXCM Stock: Price, Earnings History and SEC Filings
DexCom, Inc. (DXCM) last traded at $82.29, up 2.95% on the latest session and down 4.6% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.73 against an analyst estimate of $0.66, a beat of 10.6%.
$82.29 +2.95%
1 month-4.64%
52-week high$92.59
52-week low$54.11
Volume8.64M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DXCM earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $0.73 | $0.66 | +10.61% |
| Jun 2026 | Jul 30, 2026 | $0.70 | $0.61 | +14.75% |
| Mar 2026 | Apr 30, 2026 | $0.56 | $0.47 | +19.15% |
| Dec 2025 | Feb 12, 2026 | $0.68 | $0.65 | +4.62% |
DXCM beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for DXCM
SEC filing data is not available right now. You can search for DXCM on SEC EDGAR.
DXCM news
- DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectoryNov 1, 2026 · finance.yahoo.com
- DexCom (DXCM) Stock Looks Below Fair Value on Cash FlowOct 31, 2026 · finance.yahoo.com
- DexCom (DXCM) Brings Its 15 Day Glucose Monitor To CanadaOct 31, 2026 · finance.yahoo.com
- Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes OffOct 30, 2026 · finance.yahoo.com
- Dexcom IncOct 30, 2026 · 247wallst.com
- DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC SaysOct 30, 2026 · finance.yahoo.com
- Dexcom (DXCM) Q3 2026 Earnings Call TranscriptOct 30, 2026 · fool.com
- DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseOct 30, 2026 · finance.yahoo.com
About DexCom, Inc.
DexCom, Inc. (DXCM) is a US-listed public company on Nasdaq.